Diagnostics & Tools January 2022

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• PreventionGenetics was acquired by Exact Sciences for $190mm
• Sema4 has agreed to acquire GeneDx for approximately $620mm
• Freenome received $290mm in a round of funding from The Roche Venture Fund